IRIS
PRIORI, SILVIA GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.455
EU - Europa 10.145
AS - Asia 7.363
SA - Sud America 559
AF - Africa 93
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 15
Totale 30.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.365
CN - Cina 5.862
IE - Irlanda 2.598
UA - Ucraina 1.675
RU - Federazione Russa 1.159
DE - Germania 1.078
IT - Italia 1.068
SG - Singapore 999
FI - Finlandia 884
SE - Svezia 743
BR - Brasile 498
GB - Regno Unito 467
FR - Francia 247
HK - Hong Kong 151
CA - Canada 73
JP - Giappone 63
AT - Austria 50
NL - Olanda 49
MU - Mauritius 40
IN - India 39
PK - Pakistan 30
IR - Iran 27
BE - Belgio 22
TR - Turchia 21
AR - Argentina 19
ES - Italia 18
AU - Australia 17
IQ - Iraq 17
UZ - Uzbekistan 16
ID - Indonesia 14
PT - Portogallo 14
EG - Egitto 13
EU - Europa 13
MA - Marocco 13
CH - Svizzera 12
IL - Israele 12
PL - Polonia 12
BD - Bangladesh 11
MX - Messico 11
NP - Nepal 11
ZA - Sudafrica 11
EC - Ecuador 9
PH - Filippine 9
SK - Slovacchia (Repubblica Slovacca) 9
JO - Giordania 8
CL - Cile 7
CZ - Repubblica Ceca 7
KR - Corea 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
CO - Colombia 6
GR - Grecia 6
KZ - Kazakistan 6
PY - Paraguay 6
VE - Venezuela 6
VN - Vietnam 6
AM - Armenia 5
GE - Georgia 5
KE - Kenya 5
MY - Malesia 5
PE - Perù 5
TW - Taiwan 5
AZ - Azerbaigian 4
KG - Kirghizistan 4
QA - Qatar 4
AE - Emirati Arabi Uniti 3
LU - Lussemburgo 3
MT - Malta 3
NO - Norvegia 3
SA - Arabia Saudita 3
TN - Tunisia 3
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
SN - Senegal 2
SO - Somalia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
HN - Honduras 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
OM - Oman 1
PS - Palestinian Territory 1
SI - Slovenia 1
TH - Thailandia 1
Totale 30.652
Salva come PNG Salva come JPEG
Città #
Dublin 2.595
Chandler 2.494
Jacksonville 2.150
Nanjing 1.740
Boardman 930
Ashburn 834
Nanchang 741
Princeton 651
Lawrence 586
Wilmington 540
Hebei 530
Changsha 481
Shenyang 453
Singapore 383
Jiaxing 375
Medford 375
Beijing 328
Helsinki 302
Tianjin 302
San Genesio Ed Uniti 257
Hangzhou 238
Moscow 232
Woodbridge 197
Milan 186
Shanghai 184
Hong Kong 138
Ann Arbor 125
Verona 111
Norwalk 107
Falls Church 93
Falkenstein 84
New York 83
Seattle 74
Los Angeles 70
Nuremberg 64
Des Moines 55
Toronto 52
Fairfield 49
Houston 47
Tokyo 47
Kunming 43
São Paulo 38
Washington 37
Rome 36
Chicago 32
Jinan 32
Zhengzhou 32
Ningbo 29
Tappahannock 29
Dearborn 28
Pavia 27
Guangzhou 23
Taizhou 22
Vienna 22
Rio de Janeiro 21
Changchun 19
Brussels 18
London 18
Lanzhou 15
Missoula 15
Munich 14
Pune 14
Belo Horizonte 12
Mykolayiv 12
Orange 12
Palermo 12
Tashkent 12
Auburn Hills 11
Borås 11
Turin 11
Naples 10
Brasília 9
Berlin 8
Kathmandu 8
Melito di Napoli 8
Piscataway 8
Saint Petersburg 8
Salvador 8
San Francisco 8
São Bernardo do Campo 8
The Dalles 8
Amman 7
Bari 7
Cairo 7
Dallas 7
Florence 7
Hyderabad 7
Istanbul 7
Lahore 7
Madrid 7
Monza 7
Peshawar 7
Semarang 7
Zanjan 7
Baghdad 6
Curitiba 6
Fuzhou 6
Genoa 6
Joinville 6
Melbourne 6
Totale 20.158
Salva come PNG Salva come JPEG
Nome #
Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 193
Calcio antagonisti e aritmie da riperfusione miocardica 172
Tachicardia Ventricolare Polimorfa Catecolaminergica 136
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 127
American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American college of cardiology/european society of cardiology clinical expert consensus documen on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 118
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 114
A method of gene transfer for the treatment of recessive CPVT 111
La Sindrome di Brugada: aspetti clinici, criteri diagnostici, stratificazione prognostica. 97
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 94
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. American College of Cardiology Foundation/American Heart Association Task Force. 91
La Sindrome di Brugada 91
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 91
European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. 89
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 85
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology 85
Gene-specific therapy for inherited arrhythmogenic diseases 84
Risk stratification in the Long-QT Syndrome 84
Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. 84
Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. 84
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 84
Molecular strategies for the electrophysiologist 82
Computer simulation of wild-type and mutant human cardiac Na+ current 82
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 81
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 81
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 80
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease 80
Long QT syndrome and catecholaminergic VT 79
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 78
Spotlight on sudden cardiac death 78
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 78
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 78
Catecholaminergic Polymorphic Ventricular Tachycardia. 77
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 77
Beyond Cohort Selection: An Analytics-Enabled i2b2 77
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 77
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 76
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 75
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 75
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 74
Cardiac Sodium Channel Diseases 74
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 74
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society 73
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 73
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 73
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 73
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 73
Universal definition of myocardial infarction. 73
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 73
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 72
SUDDEN CARDIAC DEATH 72
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 72
Universal definition of the myocardial infarction 71
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 71
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 71
Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American college of cardiology/european society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 70
Guidelines On Diabetes, Pre-Diabetes, And Cardiovascular Diseases: Executive Summary.The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). 70
Inherited arrhythmia: present and future perspectives for genetic therapy 70
Adrenergic Arrhythmogenesis and The Long QT syndrome 70
Inherited arrhythmogenic diseases 70
2010 Focused Update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 70
Genetic causes of sudden cardiac death in the young. 70
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 70
Evaluation of BLS-D training in lay people. 69
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 69
Update of the guidelines on sudden cardiac death of the European Society of Cardiology 69
Ryanodine receptor and calsequestrin in arrhythmogenesis: What we have learnt from genetic diseases and transgenic mice 69
Acute oral drug testing in the evaluation of a new antiarrhythmic agent: Penticainide (CM 7857) 69
Molecular genetics: is it making an impact in the management of inherited arrhythmogenic syndromes? 69
Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary 69
Idiopathic Ventricular Fibrillation. 69
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 69
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 69
Task Force Members; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology 68
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 68
Genetics of ion-channel disorders 68
Proposed Diagnostic Criteria for the Brugada Syndrome. 68
Catecholaminergic Polymorphic Ventricular Tachycardia, Recurrent Syncope, and Implantable Loop Recorder 67
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 67
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 67
Basi genetiche della morte cardiaca improvvisa 67
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 67
Gene therapy to treat cardiac arrhythmias 67
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 66
R Engine Cell: integrating R into the i2b2 software infrastructure. 66
L-TYPE CALCIUM CHANNEL DISEASE 66
“Cardiac Risk Stratification by NOS1AP Genotyping” 66
Unexplained cardiac arrest. The need for a prospective registry. 66
Information extraction from Italian medical reports: An ontology-driven approach 66
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary 66
Gender-specific prescription for cardiovascular diseases? 65
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 65
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 65
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 65
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 65
A Recessive Variant of the Romano-Ward Long QT Syndrome 65
New mutations in the KVLQT1 potassium channel that cause long QT Syndrome. 65
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. 65
ST-Segment Elevation in the Setting of a Febrile Illness. 65
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 65
Drug-induced torsades de pointes and implications for drug development. 65
Totale 7.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 141.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.965
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020649 0 0 0 0 0 0 0 0 0 440 202 7
2020/20213.187 357 304 102 307 4 415 18 489 183 475 420 113
2021/20222.393 18 6 64 22 53 124 61 138 183 113 372 1.239
2022/20237.411 879 426 86 632 730 835 7 379 3.047 34 229 127
2023/20242.867 308 512 113 276 291 700 128 156 17 84 90 192
2024/20254.761 166 703 206 263 184 284 470 712 1.690 83 0 0
Totale 31.062